Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Open accessThe DOI matches its Crossref record; 235 of the 239 references it cites were found in a registry or an index.
Abstract
These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT). Although there are many reassuring retrospective studies on the efficacy and safety of OPAT, few prospective studies have been conducted to compare the risks and outcomes for patients who receive treatment as outpatients rather than as inpatients. Because truly evidence-based studies are lacking, the present guidelines are formulated from the collective experience of the committee members and advisors from related organizations. Important aspects of OPAT are described in the text and tables and include the following: The literature supports the effectiveness of OPAT for a wide variety of infections (table 1 and the Appendix). Infections treated with outpatient parenteral antimicrobial therapy (OPAT) and the antibiotics used in 4 studies or sites. A thorough assessment of the patient's general medical condition, the infectious process, and the home situation is necessary before starting therapy (table 2) Specific considerations in evaluating patients for outpatient parenteral antimicrobial therapy (OPAT). Prescribing physicians should be aware of a number of aspects of OPAT which distinguish it from other forms of therapy. These include the required teamwork, communication, monitoring, and outcome measurements (tables 3 and 4). Key elements required for an outpatient parenteral antimicrobial therapy (OPAT) program. Key elements required for evaluating an outpatient parenteral antimicrobial therapy (OPAT) program when the patient is to be referred. The physician has a unique role on the OPAT team, which may also include nursing, pharmacy, and social services. These responsibilities include establishing a diagnosis, prescribing treatment, determining the appropriate site of care, monitoring during therapy, and assuring the overall quality of care. Antimicrobial selection for OPAT is different from that for therapy in the hospital. Once-daily drug administration has many advantages. Potential for adverse effects and the stability of an antimicrobial once it is mixed must be considered (tables 5–7). Properties of commonly prescribed antimicrobials at various temperatures. Suggestions for laboratory parameters that should be monitored weekly during outpatient parenteral antimicrobial therapy (OPAT). The importance of administering the first dose of an antibiotic in a supervised setting is emphasized. Regular clinical and laboratory monitoring of patients receiving OPAT is essential and varies with the antimicrobial chosen (table 8). Outcome measures for outpatient parenteral antimicrobial therapy (OPAT). Outcomes measures should be an integral part of any OPAT program, to assure the effectiveness and quality of care (table 9). Internet resources with information on outpatient parenteral antimicrobial therapy (OPAT). Children receiving OPAT must be considered differently because of their special needs. The practice of administering intravenous antimicrobial therapy in the home and in alternate care settings has grown rapidly since it was first described in 1974 by Rucker and Harrison [1]. The most common infections treated and antimicrobials used by a variety of programs are shown in table 1. In the United States, OPAT is estimated to be a multibillion-dollar-a-year industry and is provided to 1 in 1000 Americans each year [10]. The growth of OPAT has been fueled by a variety of factors including the push for cost containment, the development of antimicrobial agents that can be administered once daily, technological advances in vascular access and infusion devices, increased acceptance of such therapy by both patients and health care personnel, and the availability of reliable and skilled services for OPAT in the community. Although OPAT has become widely accepted as a form of medical therapy (see Appendix), more information is needed regarding its benefits, safety, and limitations. This is especially true with the economic incentives for early discharge that exist for payors. These guidelines update those written in 1997 [11] and are intended to ensure successful implementation of parenteral antimicrobial services for patients in varied community settings, including the home and outpatient facilities, such as physicians' offices, hospital clinics, ambulatory-care centers, day hospitals, and skilled nursing facilities. They have been formulated to incorporate the perspectives of the team of physicians, nurses, pharmacists and other health care professionals necessary for an effective and safe program [6, 8, 12]. Advice and participation were requested of the leading infusion-nurse, pharmacy, and to a on the The were formulated from the collective clinical experience of the of and from the organizations. In the of the and quality of in of OPAT is by a of prospective studies and a number of are The information can a for programs to
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Guidelines for the prevention of intravascular catheter-related infections
da Silva, G. D., de Almeida, V. S., Querido, D. L., Esteves, A. P. V. D. S., dos Santos, J. P. O., & Rezende, T. F. (2012) · doi:10.5205/3705 · Cited by 1,119
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1418 · Cited by 1,045
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia
Meehan, T. P. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550230056037 · Cited by 919
Research works printed but not linked: 28
- Winters, 1992, Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy, 1
- Hankwitz, 1994, The expanding and increasingly important role of the home health care agency medical director, Am Ac Home Care Phys Newsletter, 6, 8
- Tice, 1993, Growing pains in outpatient intravenous antibiotic therapy, Infect Dis Clin Pract, 1, 74
- 1986, Wickline v State of California, 228 Cal. Rptr. 661, 192. Cap. App. 3d 1630
- 1981, Physicians, surgeons and other healers. American Jurisprudence, 226
- Tice, 1997, Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient parenteral antimicrobial therapy: current status, 7
- Residency Review Committee, Specific program content. CAAR Program Information from Workshop for Internal Medicine Subspecialty Residencies in Infectious Disease. 11. 2001. American Board of Internal Medicine. Ref Type: Conference Proceeding.
- Lonsway, 2001, Intravenous therapy in the home, 501
- Mortlock, 2001, Intravenous therapy in the alternative care setting, 535
- Skokal, 2000, IV push at home?, RN, 63, 26
- Tice, 2002, Adverse effects with intravenous antibiotics with OPAT
- Rehm, 2000, Rates of adverse events associated with community-based parenteral anti-infective therapy, J Clin Outcomes Manage, 7, 23
- Martinelli, 1988, Aminoglycoside questionnaire results
- Hautekeete, 1995, Hepatotoxicity of antibitoics, Acta Gastroenterol Belg, 58, 290
- 1999, 2000–2001 Comprehensive accreditation manual for ambulatory care
- Barrell, 1998, ORYX: outcomes measurement and accreditation, Infusion, May, 37
- Poole, 1998, Outcomes measurements: making sense of the data, Infusion, May, 25
- Tice, 2000, Documenting the value of OPAT: outcomes studies and patient registries, Can J Infect Dis, 10, 45
- Tice, 2000, Outcomes registry for outpatient IV antimicrobial therapy, Infusion, May, 27
- Outpatient Parenteral Antimicrobial Therpay Outcomes Registry Web site
- Tice, 2003, Reasons for failures with OPAT [abstract 293]
- Arditi, 1990, Convalescent outpatient therapy for selected children with acute bacterial meningitis, Semin Pediatr Infect Dis, 1, 404
- Sudela, 1990, Nursing aspects of pediatric home infusion therapy for the treatment of serious, Semin Pediatr Infect Dis, 1, 306
- Tice, 2003, OPAT outcomes registry evaluaton of diabetic extremity infections [abstract 291]
- Wai, 1999, A cost analysis of an outpatient parenteral antibiotic program (OPAT): a Canadian teaching hospital and ministry of health perspective, 133
- Tice, 1997, Osteomyelitis
- Rehm, 1992, Home intravenous antibiotic therapy (HIVAT) for endocarditis
- Gentry, 1989, New approches to the diagnosis and treatment of infective endocarditis, Texas Heart Institute J, 16, 250
Cited by
Items 301–400 of 575
Outpatient Parenteral Antimicrobial Therapy in Young Infants
Krah, N. M., Olson, J. A., Thorell, E. A., Esquibel, L., Osguthorpe, R. J., Pavia, A. T., & Hersh, A. L. (2018) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piy002 · Cited by 14
Safety of Nurse- and Self-Administered Paediatric Outpatient Parenteral Antimicrobial Therapy
Sriskandarajah, S., Ritchie, B. K., Sluggett, J. K., & Reynolds, J. G. H. A. K. J. (2020) · Antibiotics · doi:10.3390/antibiotics9110761 · Cited by 14
Clinical Experience With Daptomycin for Outpatient Parenteral Antibiotic Therapy
Larioza, J., Brown, R. B., & Girard, A. W. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31821e1e6b · Cited by 14
Vaz, L. E., Farnstrom, C. L., Felder, K. K., Guzman‐Cottrill, J. A., Rosenberg, H., & Antonelli, R. C. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix023 · Cited by 14
Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis
Pedersen, M. G., Jensen‐Fangel, S., Olesen, H. V., Tambe, S. P., & Petersen, E. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1019-4 · Cited by 14
Prosthetic joints: shining lights on challenging blind spots
Saeed, K. B. A., Dryden, M., Bassetti, M., Bonnet, É., Bouza, E., Chan, M., Cortes, N., Davis, J. S., Esposito, S., Giordano, G., et al. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.10.015 · Cited by 14
Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care
Rajaratnam, D., & Rajaratnam, R. (2023) · Antibiotics · doi:10.3390/antibiotics12020355 · Cited by 13
Home intravenous therapy: Accessibility for Canadian children and youth
Moore, D., Bortolussi, R. A., & Canadian Paediatric Society (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.2.105 · Cited by 13
Lane, S., Johnston, K., Sulham, K. A., Syed, I. A., Pollack, C. V., Holland, T. L., & Nathwani, D. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.01.007 · Cited by 13
Triffault-Fillit, C., Ferry, T., Perpoint, T., Adélaïde, L., Tho, S. L. N., Ader, F., Chidiac, C., & Valour, F. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.09.008 · Cited by 13
Mattingly, T. J., Meninger, S. L., & Heil, E. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210271 · Cited by 13
Friedman, N. D., Lim, S. M., James, R. S., Ingram, R., O’Reilly, M., Pollard, J., Koning, S. I., George, C., Rajkhowa, A., Johnson, D. F., et al. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa058 · Cited by 13
Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical Unit
Yan, Y., Tonks, K., Singh, M., Kavi, J., & Langford, N. J. (2011) · Acute Medicine Journal · doi:10.52964/amja.0451 · Cited by 13
Pajarón, M., Lisa-Gracia, M., Fernández-Miera, M. F., Dueñas, J. C., Allende, I., Arnáiz, A., Sanroma, P., de Berrazueta, J. R., & Fariñas, M. C. (2017) · Hospital Practice · doi:10.1080/21548331.2017.1398588 · Cited by 13
Lewis, P. O., Jones, A., Amodei, R. J., & Youssef, D. A. (2018) · Journal of Pharmacy Practice · doi:10.1177/0897190018804964 · Cited by 13
Antibiotic Classification and Indication Review for the Infusion Nurse
Percival, K. M. (2017) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000207 · Cited by 13
Ingram, P. R., Sulaiman, Z., Chua, A., & Fisher, D. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm449 · Cited by 13
Minotti, C., Barbieri, E., Giaquinto, C., & Donà, D. (2021) · Pathogens · doi:10.3390/pathogens10101343 · Cited by 12
Campbell, P. O., Gallagher, K., Dalton, S. C., Metcalf, S. C. L., Douglas, N. M., & Chambers, S. T. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.06.008 · Cited by 12
Drug Shortages and Patient Safety: An Overview of Essential Information for the Infusion Nurse
McLaughlin, M. M., & Skoglund, E. W. (2015) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000101 · Cited by 12
Principles of Antimicrobial Therapy in Older Adults
Bradley, S. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.02.009 · Cited by 12
Moore, N., Kohut, M. R., Stoddard, H., Burris, D., Chessa, F., Sikka, M. K., Solomon, D. A., Kershaw, C. M., Eaton, E., Hutchinson, R. N., et al. (2022) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361221126868 · Cited by 12
Vancomycin and Home Health Care
Fraser, T. G., Stosor, V., Wang, Q., Allen, A., & Zembower, T. (2005) · Emerging infectious diseases · doi:10.3201/eid1110.050336 · Cited by 12
Pharmacokinetics and Pharmacogenomics of β-Lactam-Induced Neutropenia
Hahn, A., Fukuda, T., Hahn, D., Mizuno, T., Frenck, R. W., & Vinks, A. A. T. M. M. (2016) · Pharmacogenomics · doi:10.2217/pgs-2015-0008 · Cited by 12
Group B Streptococci Screening Before Repeat Cesarean Delivery: A Cost-Effectiveness Analysis
Albright, C. M., MacGregor, C. A., Sutton, D. M., Theva, M., Hughes, B. L., & Werner, E. F. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001800 · Cited by 12
Jacobs, D. M., Leung, W.-Y., Essi, D., Park, W., Shaver, A. L., Claus, J., Ruh, C. A., & Rao, G. G. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818000456 · Cited by 12
Delivering intravenous therapy in the community setting
O’Hanlon, S., Glenn, R., & Hazler, B. (2008) · Nursing Standard · doi:10.7748/ns2008.04.22.31.44.c6444 · Cited by 12
Limited role for outpatient parenteral antibiotic therapy for community‐acquired pneumonia
Ingram, P. R., CERBE, L., Hassell, M., WILSON, M., & Dyer, J. R. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01370.x · Cited by 11
Clinical Outcomes of a Veterans Affairs Outpatient Antimicrobial Treatment Program
Mohammadi, S., MacKay, K., Ward, T. T., & Forrest, G. N. (2013) · Southern Medical Journal · doi:10.1097/smj.0b013e3182967e8f · Cited by 11
Pérez‐López, J., Pardos‐Gea, J., San‐José, A., Almirante, B., Oltean, D. M., & Vilardell, M. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2011.03.028 · Cited by 11
FARRY, J., Miles, C., Collins, C. D., & Malani, P. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00377.x · Cited by 11
Restelli, U., Bonfanti, M., Croce, D., Grau, S., Metallidis, S., Moreno, S., Pacelli, V., Rizzardini, G., Soro, M., Vozikis, A., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031356 · Cited by 11
Stein, G. E., Schooley, S. L., Havlichek, D. H., & Nix, D. E. (2008) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318168fff6 · Cited by 11
Lewis, P. O., Khan, I., & Patel, P. D. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12609 · Cited by 11
Dalai, A. S., Leung, W., Johnson, H., & Bai, A. D. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae613 · Cited by 10
Ashraf, H., Nadeem, Z. A., Rehman, K. A., Akhtar, S., Ashfaq, H., Khan, M. S., Butt, M., Hassan, I. N., Fatima, E., Waqas, M., et al. (2025) · Clinical Cardiology · doi:10.1002/clc.70147 · Cited by 10
Kutubi, A., O’Brien, L., Murphy, B., Fitzpatrick, P., Hurson, C. J., Rajendran, D., Feeney, E. R., Mallon, P. W. G., & Waqas, S. (2022) · Heliyon · doi:10.1016/j.heliyon.2023.e15212 · Cited by 10
Actinomyces europaeusIsolated from a Breast Abscess in a Penicillin-Allergic Patient
White, S. E., & Woolley, S. (2018) · Case Reports in Infectious Diseases · doi:10.1155/2018/6708614 · Cited by 10
In Vitro Synergism of Penicillin and Ceftriaxone against Enterococcus faecalis
Thieme, L., Briggs, S. E., Duffy, E., Makarewicz, O., & Pletz, M. W. (2021) · Microorganisms · doi:10.3390/microorganisms9102150 · Cited by 10
Kaul, C. M., Haller, M. D., Yang, J., Solomon, S., Khan, M. R., Pitts, R. A., & Phillips, M. (2023) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2023.216 · Cited by 10
Chemical Stability of Telavancin in Elastomeric Pumps
Sand, P., Aladeen, T. S., Kirkegaard, P., LaChance, D., & Slover, C. M. (2015) · Current Therapeutic Research · doi:10.1016/j.curtheres.2015.10.002 · Cited by 10
Sanroma, P., Muñoz, P., Mirón-Rubio, M., Aguilera, A., Estrada, O., García, D., Ramallo, V. J. G., Pajarón, M., Sgaramella, G. A., González, C. R., et al. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0065 · Cited by 10
Yadav, K., Suh, K. N., Eagles, D. A., Thiruganasambandamoorthy, V., Wells, G. A., & Stiell, I. G. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.02.023 · Cited by 10
Zinzi, D., Vlachaki, I., Falla, E., Mantopoulos, T., & Nathwani, D. (2022) · The European Journal of Health Economics · doi:10.1007/s10198-022-01432-2 · Cited by 9
Bradley, A. C., Wingler, M. J. B., Artman, K. L., Ward, L. M., & Lucar, J. A. (2023) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361231195966 · Cited by 9
Mohammed, S. A., Roberts, N. A., Nicolás, D., Unwin, S., Cotta, M. O., Roberts, J. A., & Sime, F. B. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102938 · Cited by 9
Oral Parenteral Antimicrobial Therapy Administration in a Homeless Population
Hernandez, W., Price, C. S., Knepper, B. C., McLees, M. P., & Young, H. L. (2016) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000165 · Cited by 9
Stephens, J., Houfi, A. E., Javed, N., Solem, C. T., Macahilig, C. P., Raghubir, N., Chambers, R. B., Li, J., & Haider, S. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s78786 · Cited by 9
Agranulocytosis from Outpatient Antimicrobial Treatment with Ceftriaxone: A Case Report
Genchanok, Y., Tolu, S. S., Wang, H., & Arora, S. (2019) · The Permanente Journal · doi:10.7812/tpp/18-190 · Cited by 9
Parsonson, F., Legg, A., Halford, M., & McCarthy, K. L. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105975 · Cited by 9
Healthcare Utilization Patterns for Patients with a History of Substance Use Requiring OPAT
Ashraf, B., Hoff, E., Brown, L. S., Smartt, J. L., Mathew, S., Bird, C. E., Collins, R. A., Johnson, D. H., Marambage, K., & Bhavan, K. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab540 · Cited by 9
Murray, C. C., Twiddy, M., Meads, D. M., Hess, S., Wright, J. M., Mitchell, E., Hulme, C. T., Dodd, S., Gent, H., Gregson, A., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008965 · Cited by 9
Chronic Wounds of the Lower Extremity: A Preliminary Performance Measurement Set
Harlin, S. L., Willard, L. A., Rush, K. J., Ghisletta, L., & Meyers, W. C. (2008) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000294969.68930.06 · Cited by 9
Ho, J., Archuleta, S., Tice, A. D., & Fisher, D. A. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31824f8acb · Cited by 9
Self-citationAbout the Guidelines for Outpatient Parenteral Antimicrobial Therapy
Sánchez, M. Á. G., Sampedro, M. M., Orbáiz, C. G., Macazaga, J. A. C., & Aramendi, E. A. (2004) · Clinical Infectious Diseases · doi:10.1086/425507 · Cited by 9
Brand, H., Fryer, M., Mehdi, A. M., Melon, A., Morcombe, B., Choong, K., & Subedi, S. (2024) · Internal Medicine Journal · doi:10.1111/imj.16394 · Cited by 8
Sanchez, J. F., Rodgers, R., Maknojia, A., Shaikh, N., Yan, H. H., Mejia, M. E., Hendricks, H., Jenq, R. R., Reddy, P. R., Banerjee, R., et al. (2024) · HemaSphere · doi:10.1002/hem3.70038 · Cited by 8
Management of COPD in a Hospital-at-Home Setting at a Peripheral Spanish Hospital: 8-Year Experience
Carretero, R. G., Gómez, O. V., Heredia, E. L., Vargas-Rojo, B., Cotarelo, M., & Naranjo-Mansilla, G. (2022) · Home Health Care Management & Practice · doi:10.1177/10848223211073710 · Cited by 8
Outpatient parenteral antimicrobial therapy in Germany: a prospective cohort study protocol
Scholten, N., Leisse, C., Brandes, V., Oberröhrmann, C., Ihle, P., Peter, S., Hagemeier, A., Hellmich, M., Lindemann, C. H., Samel, C., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061417 · Cited by 8
Hirai, Y., Ainoda, Y., Shoji, T., & Totsuka, K. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0033-0 · Cited by 8
Tratamiento antimicrobiano parenteral domiciliario: análisis prospectivo de los últimos 12 años
Cantero, M. J. P., Rodríguez, A. M., Cardona, A. L. U., & Ortiz, A. J. (2013) · Anales de Pediatría · doi:10.1016/j.anpedi.2013.05.009 · Cited by 8
Eby, J. C., Lane, M., Horberg, M. A., Gentry, C. N., Coffin, S. E., Ray, A. J., Sheridan, K. R., Bratzler, D. W., Wheeler, D. A., Sarumi, M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy814 · Cited by 8
Building Capacity in Long-Term Care: Supporting Homes to Provide Intravenous Therapy
Παπαϊωάννου, Α., Hazzan, A. A., Ioannidis, G., O'Donnell, D. J. P., Broadhurst, D., Navare, H., Hillier, L. M., Simpson, D., & Loeb, M. B. (2018) · Canadian Geriatrics Journal · doi:10.5770/cgj.21.327 · Cited by 8
Huskey, M., Lewis, P. O., & Brown, S. D. (2020) · Hospital Pharmacy · doi:10.1177/0018578720925389 · Cited by 8
Endocarditis in the 21(st) Century.
Baluta, M. M., Benea, E. O., Stanescu, C. M., & VINTILA, M. M. (2011) · PubMed · Cited by 8
Bauer, K. A. A., Mangino, J. E., Paolo-Hohman, D., & Goff, D. A. (2016) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000445 · Cited by 8
Certain, L., Benefield, R. J., Newman, M. G., Zhang, M., & Thomas, F. O. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac199 · Cited by 7
Yang, A., Fung, R., BRUNTON, J. L., & Dresser, L. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/754897 · Cited by 7
Lund, A., Joo, D., Lewis, K., Arikan, Y., & Grunfeld, A. (2013) · Canadian Journal of Emergency Medicine · doi:10.2310/8000.2013.130726 · Cited by 7
Outpatient parenteral antimicrobial therapy
Bellamy, R. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.1.12 · Cited by 7
Mahatumarat, T., Pinmanee, N., Injai, W., & Chaiwarith, R. (2019) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s221430 · Cited by 7
Antifungal use via outpatient parenteral antimicrobial therapy
Chew, S. M., Heath, C. H., Petursson, C., Boan, P., Robinson, J. O., Italiano, C. M., Dyer, J. R., Manning, L. A., & Ingram, P. R. (2022) · Mycoses · doi:10.1111/myc.13513 · Cited by 7
Brenneman, E. K., Funaro, J., Dicks, K. V., Yarrington, M. E., Lee, H., Erkanli, A., Hung, F., & Drew, R. H. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad019 · Cited by 7
Hamad, Y., Nickel, K. B., Olsen, M. A. A., & George, I. A. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad662 · Cited by 7
Thelma Suau, C., Cecilia Piñera, M., Sergio Díaz, W., & Esteban Troncoso, R. (2008) · Revista chilena de infectología · doi:10.4067/s0716-10182008000500011 · Cited by 7
Al-Tamtami, N., Al-Lawati, J., & Al-Abri, S. (2011) · Oman Medical Journal · doi:10.5001/omj.2011.65 · Cited by 7
Sime, F. B., Wallis, S. C., Jamieson, C., Hills, T., Gilchrist, M. J., Santillo, M., Seaton, R. A., Drummond, F., & Roberts, J. A. (2023) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2023-003784 · Cited by 6
Ogawa, T., Kasahara, K., Ikawa, K., Shigeta, J., Komatsu, Y., Kuruno, N., Uno, K., Maeda, K., & Mikasa, K. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.05.006 · Cited by 6
Öztürk, C. N., Öztürk, C., Sigurdson, S. L., Magner, W. J., Sheedy, B., Lohman, R. F., & Moon, W. (2021) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000002720 · Cited by 6
Adverse Drug Reactions Associated with Home Parenteral Therapy
Cheong, E. A., Katelaris, C. H., Sisson, C. M., Anderson, E. A., & Byth, K. (2008) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2008.tb00386.x · Cited by 6
Brzozowski, K., Datta, R., Canterino, J. E., Malinis, M. F., & Juthani‐Mehta, M. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa358 · Cited by 6
Providing outpatient antibiotic therapy for cellulitis in primary care
Nazarko, L. (2008) · British Journal of Community Nursing · doi:10.12968/bjcn.2008.13.11.31524 · Cited by 6
Kara, A. Y., Johnson, C. S., Murray, M., Dillon, J., & Hui, S. L. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2573 · Cited by 6
Garg, S., Kauffmann, K., Othman, A., Ticehurst, R., Sharma, M., & Svirskis, D. M. (2012) · Current Pharmaceutical Analysis · doi:10.2174/157341212803341744 · Cited by 6
Hase, R., Hosokawa, N., Uno, S., Suzuki, D., Mikawa, T., Uwamino, Y., & Muranaka, K. (2014) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.88.269 · Cited by 6
Furtado, G. H. C., Rocha, J. L. L., Hayden, R., Solem, C. T., Macahilig, C. P., Tang, W. Y., Chambers, R. B., de Figueiredo, M. L. N., Johnson, C. W., Stephens, J., et al. (2019) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2019.04.003 · Cited by 6
MUSIL, D., Balejová, M., Horníková, M., Chrdle, A., Mallátová, N., Nyč, O., Chmelík, V., Gallo, J. C., Jahoda, D., & Stehlík, J. (2017) · Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca · doi:10.55095/achot2017/034 · Cited by 6
Heo, E., Choi, Y., Kim, H.-S., Namgung, H. W., Lee, E., Lee, E., Lee, J., Jung, J., Kim, E. S., Kim, H. B., et al. (2022) · Infection and Chemotherapy · doi:10.3947/ic.2022.0092 · Cited by 5
Association of Intravenous Drug Use and Length of Stay Following Infective Endocarditis
Nodoushani, A. Y., Wang, Y., Datar, Y., Mohnot, J., Karlson, K. J., Edwards, N. M., Yin, K., & Dobrilovic, N. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.10.004 · Cited by 5
Use of Clinical Practice Guideline to Improve Management of Osteoarticular Infections in Children
Dimo, J., Hahn, D. R., Schlidt, K., Mobayed, N., Dasgupta, M., Barbeau, J., Simpson, P. M., Soung, P. J., & Huppler, A. R. (2023) · Hospital Pediatrics · doi:10.1542/hpeds.2022-006822 · Cited by 5
Bogus, A., McGinnis, K., Vergin, J., May, S., Hankins, R., Stohs, E. J., Schooneveld, T. C. V., & Bergman, S. (2024) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2024.80 · Cited by 5
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and −20 °C
Jain, J. G., Sutherland, C. A., Nicolau, D. P., & Kuti, J. L. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130664 · Cited by 5
Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island.
Romo, F. T., Resnick, B., Perez-Cioe, M., Flanigan, T., Em, K., & Cg, B. (2014) · PubMed · Cited by 5
Pediatric Community-Acquired Pneumonia
Statile, A. M., Williams, D. J., & Shah, S. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00022-4 · Cited by 5
Self-citationLópez, P. M., Freixa, I. A., Gil, M. M., Espinoza, G. A., Polonio, L. O., Paredes, E. C., Sanchez, M. C., Pelluz, C. S., Pardo, J., Picó, J. N., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.713882 · Cited by 5
Outpatient Parenteral Antimicrobial Therapy Practice in United Kingdom: A Single-center Experience
Kesharwani, D., Bista, A., Singh, H., Unnithan, A., Das, G., Bristoll, S., Lewis, N., & Alnoori, N. (2022) · Oman Medical Journal · doi:10.5001/omj.2023.26 · Cited by 5
OPAT: proof of concept in a peripheral Belgian hospital after review of the literature
Smismans, A., Vantrappen, A., Verbiest, F., Indevuyst, C., den Poel, B. V., von Winckelmann, S., Peeters, A., Ombelet, S., Lybeert, P., Heremans, A., et al. (2018) · Acta Clinica Belgica · doi:10.1080/17843286.2018.1424503 · Cited by 5
Hase, R., & Hosokawa, N. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1031174 · Cited by 5
The Safety of First-Dose Home IV Antibiotic Therapy
Ma, G., Tisseverasinghe, A., Toren, P., Tam, D. M. W., McKenna, S., & Evans, G. A. (2007) · The Canadian Journal of Hospital Pharmacy · Cited by 5
Temperature variation in the home setting: implications for continuous ambulatory infusions
Sluggett, J. K., Sharley, N. A., Reynolds, K. J., & Sluggett, A. J. (2017) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1290 · Cited by 5
Metadata
- Authors
- Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Rady Children's Hospital-San Diego (US)
- Consultants in Infectious Diseases, Lubbock, Texas
- Springfield Clinic (US)
- Morgantown Internal Medicine Group, Morgantown, West Virginia
- Pfizer (United States) (US)
- Florida Infection Physicians, Gainsville
- Hennepin County Medical Center (US)
- Corresponding author
- Tice, Alan D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 38
- Issue
- 12
- Pages
- 1651-1671
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141994303
- Cited by
- 532
- References
- 239
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 18 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 31 · 2019: 38 · 2018: 48 · 2017: 40 · 2016: 43 · 2015: 32 · 2014: 36 · 2013: 31 · 2012: 21
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- outpatient parenteral antimicrobial therapy, outpatient antibiotic therapy, patient selection, antimicrobial selection, once-daily dosing, drug stability, laboratory monitoring, adverse drug reactions, quality of care, multidisciplinary team
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Home Care Services, Humans, Infusions, Intravenous, Outpatients, Patient Care Team, Pediatrics, Drug Monitoring, Outcome Assessment, Health Care, Patient Selection, Home Infusion Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.